Contract Manufacturing Services

The author discusses the upcoming human research congressional debate and CROs' preparations to respond.

The author discusses the current soft demand and excess capacity in the contract-manufacturing market of small molecule actives and intermediates.

The author discusses three current examples of new ideas in formulating outsourcing arrangments.

The author discusses current economic times and conditions for large pharmaceutical companies.

The author looks ahead to what 2002 may have in store for the contract services industry.

Capacity is a pivotal commodity in the contract manufacturing business. If you have enough of the right kind of capacity, it's like platinum; conversely, too much of the wrong kind of capacity is like tin.

Recovery of the contract services industry picked up steam in the quarter ending 30 June 2001.

The consolidation of the contract manufacturing industry has spread to the parenteral fill-finish segment, with two deals announced just before this year's Fourth of July holiday.

The author reviews year-to-date progress and growth in the pharmaceutical outsourcing industry.